Clinical Trial Update: Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload [Phase 4]

View source ↗

Summary

Open-label, single-arm Phase 4 pilot trial in adults who underwent allogeneic hematopoietic stem cell transplantation with transfusional iron overload; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Iron Overload | Phase 4 | Status: COMPLETED